Skip to main content
. 2020 Sep 26;11:2040620720947340. doi: 10.1177/2040620720947340

Table 2.

Response rates for entire cohort (n = 19).

Outcome Number, n (%)
Complete response (CR) 0
Partial response (PR) 3 (16%)
Stable disease (SD) 11 (58%)
Stable disease >6 months (SD > 6 months) 7 (37%)
Cytostatic ORR (CR + PR + SD > 6 months) 10 (53%)
Progression of disease 5 (26%)

CR, complete response; ORR, overall response rate; PR, partial response; SD, stable disease.